| 02.06.2021

Colouring tumours reveals their bad influence

Red2Onco, an innovative genetic mouse model, allows to detect the very initial steps that lead to cancer development. Red2Onco’s…

| 25.05.2021

Harnessing Next Generation Sequencing to detect SARS-CoV-2 and prepare for the next pandemic

Researchers at the Vienna BioCenter designed a testing protocol for SARS-CoV-2 that can process tens of thousands of samples in less…

| 20.05.2021

Cardioids – Heartbeat, heartbreak and recovery in a dish

Self-organizing heart organoids developed at IMBA – Institute of Molecular Biotechnology of the Austrian Academy of Sciences – are…

| 29.04.2021

15th symposium on Micro RNAs hosted in the virtual space

From April 21st to 22nd, the 15th Microsymposium took place. This time, in the virtual space of the Vienna BioCenter.

| 22.04.2021

ERC Advanced Grant to Daniel Gerlich

Daniel Gerlich, Senior Group Leader at IMBA – Institute of Molecular Biotechnology of the Austrian Academy of Sciences – secured an…

Twitter

Download

Facts and Figures

IMBA Fact Sheet

 

Press Contact

Sylvia Weinzettl

Senior Relationship Manager
+43 1 79044-4403
sylvia.weinzettl@imba.oeaw.ac.at

Daniel Azar

Communications Officer
+43 1 79044-3821
daniel.azar@imba.oeaw.ac.at